Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Receivables (2020 - 2025)

Biofrontera (BFRI) has 6 years of Change in Receivables data on record, last reported at -$947000.0 in Q3 2025.

  • For Q3 2025, Change in Receivables fell 167.45% year-over-year to -$947000.0; the TTM value through Sep 2025 reached -$1.9 million, down 262.16%, while the annual FY2024 figure was $315000.0, 79.49% down from the prior year.
  • Change in Receivables reached -$947000.0 in Q3 2025 per BFRI's latest filing, down from -$88000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.2 million in Q4 2022 and bottomed at -$3.1 million in Q2 2022.
  • Average Change in Receivables over 5 years is $8842.1, with a median of $10000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: plummeted 30900.0% in 2022, then surged 467.68% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $1.8 million in 2021, then grew by 19.7% to $2.2 million in 2022, then crashed by 38.93% to $1.3 million in 2023, then tumbled by 63.06% to $492000.0 in 2024, then tumbled by 292.48% to -$947000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$947000.0 in Q3 2025, -$88000.0 in Q2 2025, and -$1.3 million in Q1 2025.